PRZOOM - /newswire/ -
Northridge, CA, United States, 2009/05/18 - PBMI has awarded its 2009 Rx Benefit Innovation Award to the collaboration of the Coal/Energy Coalition with Pro Pharma for a physician intervention program that improves the quality of pharmaceutical care, while also lowering drug trend.
Pro Pharma Pharmaceutical Consultants, Inc. announced that they have received PBMI’s (Pharmacy Benefit Management Institute) national award for excellence in managing pharmacy benefits.
The physician intervention program, implemented by Pro Pharma for the Coal/Energy Coalition, targets prescribers in seven states that are among the highest utilizers of prescription drugs. Compelling clinical information with patient-specific opportunities to improve pharmaceutical care is a key to engaging physicians. Three-year results show improved quality leads to lower costs. In 2007, the Coalition drug trend was -3 percent compared to 8.3 percent nationally and 16 percent for the coal/energy industry.
CEO of Pro Pharma, Carol Stern, stated that “Pro Pharma was very pleased to have been selected for the award” and went on to note that Pro Pharma’s client, the Coal/Energy Coalition, was similarly honored. Ms. Stern said that Pro Pharma’s success was directly tied to its close working relationship with its coal producer clients that participate in the Coal/Energy Coalition.
Craig Stern, Pharm. D., stated “our Quality Management Program now has over four years of history with the coal producers.” He went on to note that “for the first three years pharmacy benefit costs (including retirees) increased at a rate that was well below 2% per annum; and that while the forth year is not fully analyzed, it appears that we will show a trend for the most recent year that will be well below national averages and in the low single digits once again.” Dr. Stern also noted, “What makes our results so striking is that we are operating our program in the highest cost and highest frequency regions within the United States and upon the employed and retired population that has the highest prescription rates.”
Dr. Stern thanked the coal producers for their support and willingness to collaborate with Pro Pharma. “Without the ongoing and dedicated interest and support of our clients, our QM program would certainly not have been as successful.” “We look forward to continuing success in 2009 and into the future.”
"Our 2009 award recipients have differentiated themselves from industry norms with creative new approaches," says Dana H. Felthouse, MBA, president of PBMI.
"Another hallmark of the winners is a passion for collaboration among multiple stakeholders. The solutions are programs that demonstrate success in improving pharmaceutical and health care as well as curbing costs."
The Pharmacy Benefit Management Institute provides research, continuing education, and Web resources that help health care benefit executive’s work effectively with their pharmacy benefit managers to improve the design and management of drug benefit programs.
About Pro Pharma
Pro Pharma (propharmaconsultants.com) is a multi-service, woman owned, privately held consulting firm offering a vast portfolio of services to public and private entities including self-insured employers, Taft Hartley Trusts and unions, public employers, for-profit hospitals and integrated health networks, health care insurance companies, worker's compensation insurers, small-to-medium sized HMO's, and physician groups.
As a primary service to plan sponsors for achieving below trend results, Pro Pharma provides an integrated program of administrative process improvements, clinical quality oversight, and provider/member education.
Pro Pharma’s Consulting services are grounded in the use of data and the communication of that information to define benefit trends, drivers and other analytical indicators. Pro Pharma markets Biotech Modeling™, Invoice Screening™, Quality Management Program™, and Treatment Calendar™. The Company directly markets its products in the U.S. and collaborates with partners to reach international markets.